Medilloyd Medicament Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 6.85 Cr
- Satisfied Charges ₹ 2.70 Cr
- Revenue Growth 11.49%
- Profit Growth -8.07%
- Ebitda 1.52%
- Net Worth 5.05%
- Total Assets -9.49%
About Medilloyd Medicament
Company Details
- Location
Cuttack, Odisha, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230OR2012PTC015269
- Company No.
015269
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2012
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Medilloyd Medicament?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiba Jena  | Managing Director | 20-Apr-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhalaxmi Jena | Director | 20-Apr-2012 | Current |
Financial Performance of Medilloyd Medicament.
Medilloyd Medicament Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.49% increase. The company also saw a slight decrease in profitability, with a 8.07% decrease in profit. The company's net worth moved up by a moderate rise of 5.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilloyd Medicament?
In 2020, Medilloyd Medicament had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oppurtune Ventures Private LimitedShiba Jena and Subhalaxmi Jena are mutual person
Charges (Loans)
₹6.85 Cr
₹2.70 Cr
Charges Breakdown by Lending Institutions
- Others : 4.10 Cr
- Dcb Bank Limited : 2.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2017 | Others | ₹4.10 Cr | Open |
| 24 Sep 2015 | Dcb Bank Limited | ₹2.75 Cr | Open |
| 24 Feb 2014 | Canara Bank | ₹2.70 Cr | Satisfied |
How Many Employees Work at Medilloyd Medicament?
Unlock and access historical data on people associated with Medilloyd Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilloyd Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilloyd Medicament's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
